Photoreceptor responses to light in the pathogenesis of diabetic retinopathy.
Shahriyar P MajidiRithwick RajagopalPublished in: Visual neuroscience (2020)
Vision loss, among the most feared complications of diabetes, is primarily caused by diabetic retinopathy, a disease that manifests in well-recognized, characteristic microvascular lesions. The reasons for retinal susceptibility to damage in diabetes are unclear, especially considering that microvascular networks are found in all tissues. However, the unique metabolic demands of retinal neurons could account for their vulnerability in diabetes. Photoreceptors are the first neurons in the visual circuit and are also the most energy-demanding cells of the retina. Here, we review experimental and clinical evidence linking photoreceptors to the development of diabetic retinopathy. We then describe the influence of retinal illumination on photoreceptor metabolism, effects of light modulation on the severity of diabetic retinopathy, and recent clinical trials testing the treatment of diabetic retinopathy with interventions that impact photoreceptor metabolism. Finally, we introduce several possible mechanisms that could link photoreceptor responses to light and the development of retinal vascular disease in diabetes. Collectively, these concepts form the basis for a growing body of investigative efforts aimed at developing novel pharmacologic and nonpharmacologic tools that target photoreceptor physiology to treat a very common cause of blindness across the world.
Keyphrases
- diabetic retinopathy
- optical coherence tomography
- type diabetes
- cardiovascular disease
- glycemic control
- clinical trial
- induced apoptosis
- spinal cord
- gene expression
- oxidative stress
- metabolic syndrome
- cell cycle arrest
- signaling pathway
- quality improvement
- spinal cord injury
- cell proliferation
- combination therapy
- replacement therapy
- open label
- smoking cessation